Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial by Luvira, V, Schilling, WHK, Jittamala, P, Watson, JA, Boyd, S, Siripoon, T, Ngamprasertchai, T, Almeida, PJ, Ekkapongpisit, M, Cruz, C, Callery, JJ, Singh, S, Tuntipaiboontana, R, Kruabkontho, V, Ngernseng, T, Tubprasert, J, Abdad, MY, Keayarsa, S, Madmanee, W, Aguiar, RS, Santos, FM, Hanboonkunupakarn, P, Hanboonkunupakarn, B, Poovorawan, K, Imwong, M, Taylor, WRJ, Chotivanich, V, Chotivanich, K, Pukrittayakamee, S, Dondorp, AM, Day, NPJ, Teixeira, MM, Piyaphanee, W, Phumratanaprapin, W, White, NJ

Clinical antiviral efficacy of remdesivir in coronavirus disease 2019: an open-label, randomized controlled adaptive platform trial (PLATCOV) by Jittamala, P, Schilling, WHK, Watson, JA, Luvira, V, Siripoon, T, Ngamprasertchai, T, Almeida, PJ, Ekkapongpisit, M, Cruz, C, Callery, JJ, Boyd, S, Anunsittichai, O, Hongsuwan, M, Singhaboot, Y, Pagornrat, W, Tuntipaiboontana, R, Kruabkontho, V, Ngernseng, T, Tubprasert, J, Abdad, MY, Keayarsa, S, Madmanee, W, Aguiar, RS, Santos, FM, Batty, EM, Hanboonkunupakarn, P, Hanboonkunupakarn, B, Sookprome, S, Poovorawan, K, Imwong, M, Taylor, WRJ, Chotivanich, V, Sangketchon, C, Ruksakul, W, Chotivanich, K, Pukrittayakamee, S, Dondorp, AM, Day, NPJ, Teixeira, MM, Piyaphanee, W, Phumratanaprapin, W, White, NJ